United Therapeutics reported $478.8M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Amarin AMRN:US USD 65.94M 7.31M
Baxter International BAX:US USD 1.15B 310M
Bayer BAYN:GR EUR 7.03B 105M
Biocryst Pharmaceuticals BCRX:US USD 72.21M 6.93M
Biogen BIIB:US USD 2.04B 66.1M
Biomarin Pharmaceutical BMRN:US USD 389.06M 21.62M
Esperion Therapeutics ESPR:US USD 12.47M 2.81M
Gilead Sciences GILD:US USD 5.65B 829M
GlaxoSmithKline GSK:LN GBP 5.44B 650M
Halozyme Therapeutics HALO:US USD 161.66M 43.24M
Insmed INSM:US USD 54.26M 5.43M
Intercept Pharmaceuticals ICPT:US USD 77.16M 5.72M
Intra Cellular Therapies ITCI:US USD 66.02M 15.09M
Johnson & Johnson JNJ:US USD 15.98B 134M
Moderna Inc MRNA:US USD 2.26B 1.1B
Pfizer PFE:US USD 16.55B 2.52B
Ptc Therapeutics PTCT:US USD 203.12M 47.23M
Regeneron Pharmaceuticals REGN:US USD 2.62B 58.3M
Sarepta Therapeutics SRPT:US USD 190.32M 5.38M
Seattle Genetics SGEN:US USD 402.18M 10.78M
Teva Pharmaceutical TEVA:IT USD 1.71B 118M
United Therapeutics UTHR:US USD 478.8M 41.6M
Vertex Pharmaceuticals VRTX:US USD 2.04B 110.5M